| UniProt ID | CD166_HUMAN | |
|---|---|---|
| UniProt AC | Q13740 | |
| Protein Name | CD166 antigen | |
| Gene Name | ALCAM | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 583 | |
| Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Cell projection, axon . Cell projection, dendrite . Detected at the immunological synapse, i.e, at the contact zone between antigen-presenting dendritic cells and T-cells (PubMed:15294938, PubMed: |
|
| Protein Description | Cell adhesion molecule that mediates both heterotypic cell-cell contacts via its interaction with CD6, as well as homotypic cell-cell contacts. [PubMed: 7760007] | |
| Protein Sequence | MESKGASSCRLLFCLLISATVFRPGLGWYTVNSAYGDTIIIPCRLDVPQNLMFGKWKYEKPDGSPVFIAFRSSTKKSVQYDDVPEYKDRLNLSENYTLSISNARISDEKRFVCMLVTEDNVFEAPTIVKVFKQPSKPEIVSKALFLETEQLKKLGDCISEDSYPDGNITWYRNGKVLHPLEGAVVIIFKKEMDPVTQLYTMTSTLEYKTTKADIQMPFTCSVTYYGPSGQKTIHSEQAVFDIYYPTEQVTIQVLPPKNAIKEGDNITLKCLGNGNPPPEEFLFYLPGQPEGIRSSNTYTLTDVRRNATGDYKCSLIDKKSMIASTAITVHYLDLSLNPSGEVTRQIGDALPVSCTISASRNATVVWMKDNIRLRSSPSFSSLHYQDAGNYVCETALQEVEGLKKRESLTLIVEGKPQIKMTKKTDPSGLSKTIICHVEGFPKPAIQWTITGSGSVINQTEESPYINGRYYSKIIISPEENVTLTCTAENQLERTVNSLNVSAISIPEHDEADEISDENREKVNDQAKLIVGIVVGLLLAALVAGVVYWLYMKKSKTASKHVNKDLGNMEENKKLEENNHKTEA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 11 (in isoform 4) | Phosphorylation | - | 5.15 | 29116813 | |
| 12 (in isoform 4) | Phosphorylation | - | 1.15 | 29116813 | |
| 52 | Sulfoxidation | LDVPQNLMFGKWKYE CCCCCCCEECEEEEE | 5.66 | 21406390 | |
| 64 | Phosphorylation | KYEKPDGSPVFIAFR EEECCCCCEEEEEEE | 25.85 | 110750185 | |
| 80 | Phosphorylation | STKKSVQYDDVPEYK CCCCCCCCCCCCCHH | 16.38 | 22817900 | |
| 86 | Phosphorylation | QYDDVPEYKDRLNLS CCCCCCCHHHHCCCC | 16.48 | 22817900 | |
| 87 | Ubiquitination | YDDVPEYKDRLNLSE CCCCCCHHHHCCCCC | 34.41 | 21906983 | |
| 87 (in isoform 2) | Ubiquitination | - | 34.41 | 21906983 | |
| 87 (in isoform 1) | Ubiquitination | - | 34.41 | 21906983 | |
| 87 | 2-Hydroxyisobutyrylation | YDDVPEYKDRLNLSE CCCCCCHHHHCCCCC | 34.41 | - | |
| 87 | Ubiquitination | YDDVPEYKDRLNLSE CCCCCCHHHHCCCCC | 34.41 | 21906983 | |
| 91 | N-linked_Glycosylation | PEYKDRLNLSENYTL CCHHHHCCCCCCEEE | 42.27 | 12754519 | |
| 95 | N-linked_Glycosylation | DRLNLSENYTLSISN HHCCCCCCEEEEEEC | 31.54 | 12754519 | |
| 95 | N-linked_Glycosylation | DRLNLSENYTLSISN HHCCCCCCEEEEEEC | 31.54 | 12754519 | |
| 117 | Phosphorylation | RFVCMLVTEDNVFEA CEEEEEECCCCEECC | 33.39 | 20639409 | |
| 126 | Phosphorylation | DNVFEAPTIVKVFKQ CCEECCCCEEECCCC | 45.51 | 20639409 | |
| 152 | 2-Hydroxyisobutyrylation | FLETEQLKKLGDCIS HHCHHHHHHHHCCCC | 45.72 | - | |
| 167 | N-linked_Glycosylation | EDSYPDGNITWYRNG CCCCCCCCEEEEECC | 35.58 | 12754519 | |
| 167 | N-linked_Glycosylation | EDSYPDGNITWYRNG CCCCCCCCEEEEECC | 35.58 | 12754519 | |
| 196 | Phosphorylation | KKEMDPVTQLYTMTS ECCCCCCCEEEEEEE | 20.46 | 24905233 | |
| 199 | Phosphorylation | MDPVTQLYTMTSTLE CCCCCEEEEEEEEEE | 5.66 | 24905233 | |
| 200 | Phosphorylation | DPVTQLYTMTSTLEY CCCCEEEEEEEEEEE | 23.67 | 24905233 | |
| 202 | Phosphorylation | VTQLYTMTSTLEYKT CCEEEEEEEEEEEEE | 15.68 | 24905233 | |
| 203 | Phosphorylation | TQLYTMTSTLEYKTT CEEEEEEEEEEEEEC | 21.85 | 24905233 | |
| 204 | Phosphorylation | QLYTMTSTLEYKTTK EEEEEEEEEEEEECC | 17.91 | 24905233 | |
| 207 | Phosphorylation | TMTSTLEYKTTKADI EEEEEEEEEECCCCE | 19.42 | 29116813 | |
| 209 | Phosphorylation | TSTLEYKTTKADIQM EEEEEEEECCCCEEC | 32.40 | 24905233 | |
| 210 | Phosphorylation | STLEYKTTKADIQMP EEEEEEECCCCEECC | 21.78 | 24905233 | |
| 265 | N-linked_Glycosylation | NAIKEGDNITLKCLG CCCCCCCCEEEEECC | 39.75 | UniProtKB CARBOHYD | |
| 265 | N-linked_Glycosylation | NAIKEGDNITLKCLG CCCCCCCCEEEEECC | 39.75 | 16335952 | |
| 298 | Phosphorylation | GIRSSNTYTLTDVRR CCCCCCEEEEECCHH | 12.19 | 110750197 | |
| 306 | N-linked_Glycosylation | TLTDVRRNATGDYKC EEECCHHHCCCCCEE | 31.15 | UniProtKB CARBOHYD | |
| 308 | Phosphorylation | TDVRRNATGDYKCSL ECCHHHCCCCCEEEE | 33.85 | 26699800 | |
| 311 | Phosphorylation | RRNATGDYKCSLIDK HHHCCCCCEEEECCC | 18.42 | 26699800 | |
| 314 | Phosphorylation | ATGDYKCSLIDKKSM CCCCCEEEECCCCHH | 24.98 | 26699800 | |
| 343 | O-linked_Glycosylation | LNPSGEVTRQIGDAL CCCCCCHHEECCCEE | 16.74 | OGP | |
| 361 | N-linked_Glycosylation | CTISASRNATVVWMK EEEEECCCCEEEEEE | 37.15 | 19349973 | |
| 361 | N-linked_Glycosylation | CTISASRNATVVWMK EEEEECCCCEEEEEE | 37.15 | 19349973 | |
| 375 | Phosphorylation | KDNIRLRSSPSFSSL ECCEEECCCCCCCCC | 51.71 | 28348404 | |
| 376 | Phosphorylation | DNIRLRSSPSFSSLH CCEEECCCCCCCCCE | 20.37 | 28348404 | |
| 378 | Phosphorylation | IRLRSSPSFSSLHYQ EEECCCCCCCCCEEE | 39.44 | 28348404 | |
| 380 | Phosphorylation | LRSSPSFSSLHYQDA ECCCCCCCCCEEECC | 36.01 | 28348404 | |
| 381 | Phosphorylation | RSSPSFSSLHYQDAG CCCCCCCCCEEECCC | 19.70 | 28348404 | |
| 407 | Phosphorylation | EGLKKRESLTLIVEG CCCCCCCCEEEEEEC | 30.59 | 26091039 | |
| 409 | Phosphorylation | LKKRESLTLIVEGKP CCCCCCEEEEEECCC | 24.58 | 26091039 | |
| 457 | N-linked_Glycosylation | TGSGSVINQTEESPY ECCCCCCCCCCCCCC | 40.33 | 19349973 | |
| 457 | N-linked_Glycosylation | TGSGSVINQTEESPY ECCCCCCCCCCCCCC | 40.33 | 19159218 | |
| 466 | N-linked_Glycosylation | TEESPYINGRYYSKI CCCCCCCCCEEEEEE | 24.05 | 19349973 | |
| 466 | N-linked_Glycosylation | TEESPYINGRYYSKI CCCCCCCCCEEEEEE | 24.05 | 19349973 | |
| 480 | N-linked_Glycosylation | IIISPEENVTLTCTA EEECCCCCEEEEEEC | 30.34 | 12754519 | |
| 480 | N-linked_Glycosylation | IIISPEENVTLTCTA EEECCCCCEEEEEEC | 30.34 | 12754519 | |
| 496 | N-linked_Glycosylation | NQLERTVNSLNVSAI HHHHHHHHEECEEEE | 39.92 | 19349973 | |
| 496 | N-linked_Glycosylation | NQLERTVNSLNVSAI HHHHHHHHEECEEEE | 39.92 | 19349973 | |
| 499 | N-linked_Glycosylation | ERTVNSLNVSAISIP HHHHHEECEEEEECC | 26.06 | 12754519 | |
| 499 | N-linked_Glycosylation | ERTVNSLNVSAISIP HHHHHEECEEEEECC | 26.06 | 12754519 | |
| 501 (in isoform 2) | Phosphorylation | - | 20.86 | 22617229 | |
| 518 | N-linked_Glycosylation | ADEISDENREKVNDQ HHCCCHHHHHHHHHH | 63.50 | 19349973 | |
| 518 | N-linked_Glycosylation | ADEISDENREKVNDQ HHCCCHHHHHHHHHH | 63.50 | 19349973 | |
| 550 (in isoform 2) | Ubiquitination | - | 7.85 | - | |
| 559 (in isoform 2) | Ubiquitination | - | 49.46 | 21906983 | |
| 559 | Acetylation | KKSKTASKHVNKDLG CCCHHHHHHHCHHCC | 49.46 | 19666643 | |
| 560 (in isoform 2) | Ubiquitination | - | 26.36 | 21906983 | |
| 563 | Ubiquitination | TASKHVNKDLGNMEE HHHHHHCHHCCCHHH | 53.92 | - | |
| 563 | Acetylation | TASKHVNKDLGNMEE HHHHHHCHHCCCHHH | 53.92 | 19666651 | |
| 567 (in isoform 2) | Ubiquitination | - | 41.83 | 21906983 | |
| 572 (in isoform 1) | Ubiquitination | - | 63.11 | 21906983 | |
| 572 | Ubiquitination | LGNMEENKKLEENNH CCCHHHHHHHHHCCC | 63.11 | 21906983 | |
| 573 (in isoform 1) | Ubiquitination | - | 73.11 | 21906983 | |
| 573 | Ubiquitination | GNMEENKKLEENNHK CCHHHHHHHHHCCCC | 73.11 | 2190698 | |
| 580 (in isoform 1) | Ubiquitination | - | 50.62 | 21906983 | |
| 580 | Ubiquitination | KLEENNHKTEA---- HHHHCCCCCCC---- | 50.62 | 21906983 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CD166_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CD166_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CD6_HUMAN | CD6 | physical | 7543097 | |
| NAR3_HUMAN | ART3 | physical | 21988832 | |
| LEG1_HUMAN | LGALS1 | physical | 28514442 | |
| FBX2_HUMAN | FBXO2 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-457 AND ASN-466, AND MASSSPECTROMETRY. | |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-91; ASN-95; ASN-457 ANDASN-480, AND MASS SPECTROMETRY. | |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-95; ASN-265 AND ASN-499,AND MASS SPECTROMETRY. | |
| "Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-91; ASN-167; ASN-480 AND ASN-499. | |